NEWS & EVENTS

Meeting the Challenges of Myocarditis Workshop

May 3 - 6, 2021
Virtual Zoom Event

Description

The National Heart, Lung and Blood Institute (NHLBI) will hold a three-(half) day workshop, ”Meeting the Challenges of Myocarditis” on May 3, 4 and 6, 2021. The workshop will evaluate the state-of-the-art in the epidemiology, clinical presentation, and pathogenesis of myocarditis and identify new research opportunities for the prevention, detection, and treatment of myocarditis.

The workshop will bring together basic, translational, and clinical scientists to fulfill the following objectives:

  1. Foster exchange of novel ideas pertaining to myocarditis among experts from diverse disciplines.
  2. Identify critical clinical and research gaps and opportunities for future research.
  3. Explore research and clinical approaches utilized in other cardiac diseases to inform research advances in myocarditis.
  4. Discuss strategies for training the next generation of researchers in the field of myocarditis.

The main talks on May 3rd and 4th will be open to the NIH community and invitees only.  The May 6th discussions will be open to invitees only.

Workshop Speakers, Panelists, Moderators

David Goff, MD, PhD (National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI), Director of the Division of Cardiovascular Sciences
Scarlet Shi, PhD, (NHLBI Program Officer)
Leslie Cooper, Jr, MD (Mayo Clinic)
Daniela Cihakova, MD, PhD (Johns Hopkins University)
Urs Eriksson, MD (GZO Zurich Regional Health Center, Wetzikon, Switzerland)
Mary N. Shepherd, MD (St. George’s University of London, London, England)
James C. Fang, MD (University of Utah, Utah, US)
Nisha A. Gilotra, MD (Johns Hopkins University, Baltimore, US)
Peter Liu, MD  (University of Ottawa Heart Institute, Ottawa, Canada)
DeLisa Fairweather, PhD (Mayo Clinic, Jacksonville, Florida)
Bruce McManus, MD, PhD (University of British Columbia)
Luigi Adamo, MD, PhD (University of Johns Hopkins, Baltimore, US)
Emily J. Tsai, MD (Colombia University, US)
John Gorcsan, MD (Penn State University, US)
Vanessa Ferreira, MD, DPhil (Oxford University, Oxford, England)
Matthias Nahrendorf, MD, PhD (Massachusetts General Hospital, Boston, US)
Matthias G. Friedrich, MD (McGill University Health Centre, Montreal, Canada)
Jonathan A. Epstein, PhD (University of Pennsylvania, Philadelphia, US)
Jennifer E. Van Eyk, PhD (Cedars-Sinai Medical Center, Los Angeles, CA)
Javid Moslehi, MD (Vanderbilt School of Medicine, Nashville, US)
Ntobeko A. B. Ntusi, MB ChB, DPhil, MD (University of Cape Town and Groote Schuur Hospital, Observatory, South Africa)
Douglas L. Mann, MD (Washington University School of Medicine)
Kory Lavine, MD, PhD (Washington University School of Medicine, St Louis, US)
W.H. Wilson Tang, MD (Cleveland clinic, Cleveland, US)
Andre ́s Hidalgo, PhD (Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain)
Slava Epelman, MD, PhD (University of Toronto, Toronto, Canada)
Cristina Gil-Cruz, PhD (Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland)
Jeff Towbin, MD (University of Tennessee Health Science Center)